ADM to Present Extended Health and Wellness Offering at CPhI 2018

News
Article

At this year’s CPhI Worldwide congress in Madrid, Spain, Archer Daniels Midland Company (ADM) will present its range of products spanning probiotics and microbiome solutions to highly purified, injectable-grade vegetable oils.

At this year’s CPhI Worldwide congress in Madrid, Spain, Archer Daniels Midland Company (ADM) will present its range of products spanning probiotics and microbiome solutions to highly purified, injectable-grade vegetable oils.

Visitors to booth 8C122 will be able to view the company's bioactive portfolio as well as the pharmaceutical-grade purified vegetables oils for use as APIs and excipients in injectable, oral, or topical formulations from ADM SIO. Innovative concepts to be showcased during the event include probiotic sticks and probiotic capsules. 

Additionally, there will be research data assessing the potential of these probiotics in the treatment and prevention of atopic dermatitis and mild to moderate psoriasis-as well as for use in weight management-accessible at the booth and may be discussed further with ADM Biopolis staff.

“Our world-class R&D team continues to explore future applications for our microbial technologies in line with increased demand for innovation and personalized nutrition solutions,” explained Daniel Ramon Calvo, marketing and communications manager, ADM Biopolis, in a press release. “Now as ADM, we have expertise across all stages of product development. This in-depth knowledge means we can support both pharmaceutical and food supplement customers in creating the next generation microbiome and biotech-based products for better living. We are, for instance, specialists in microbial strain and bioprocess design and development through cell factories.”

“Excipients are used in all drug formulations and are essential for product manufacturing and performance. We take advantage of our purification and analytical expertise to offer highly purified oils from vegetable origins, produced in our cGMP workshops, and compliant with the latest requirements from the main health authorities,” added Hervé Sibillat, general manager, ADM SIO, in the same press release.

Source: ADM

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content